ISS says Icahn's Lear bid not high enough
46324
Institutional Shareholder Services is recommending that Lear Corp.  shareholders vote against Carl Icahn's $2.86 billion proposed takeover of the U.S. auto-parts maker because of its price, according to a copy of the report obtained on Thursday.
574020
Influential advisory firm Institutional  Shareholder Services has recommended that shareholders vote  against billionaire Carl Icahn&#39;s sweetened $3 billion buyout  offer for Lear Corp.
231664
Fund manager Brandes Investment Partners LP said on Friday it intended to vote against billionaire investor Carl Icahn's proposed $2.31 billion buyout offer for Lear Corp. , which the auto parts maker has accepted.
277647
Investor Carl Icahn on Friday said he has no plans to raise his $36-per-share offer for auto parts maker Lear Corp. , saying the price is "fair."
97449
Investor Carl Icahn on Thursday detailed his objections to Mylan Laboratories Inc.&#39;s proposed $4 billion acquisition of King Pharmaceuticals Inc.
386076
In a letter to the board of directors at Mylan Laboratories (nyse: MYL - news - people ), financier Carl Icahn questioned their silence on the recent financial restatements by King Pharmaceuticals (nyse: KG - news - people ), calling the &quot;lack of
442570
Icahnâs American Real Estate Partners had improved its offer in the past week to $37.25 a share, but some shareholders said Lear was worth far more.
274441
Shareholders at Lear Corporation are to vote on a $2.9bn buyout offer from billionaire investor Carl Icahn.
331749
Not buying it. Megafinancier Carl Icahn has made it clear: He&#39;s still opposed to Mylan Laboratories&#39; (nyse: MYL - news - people ) proposed acquisition of King Pharmaceuticals (nyse: KG - news - people ). Despite
750826
Auto parts supplier Lear Corp.  said on Monday that a company affiliated with activist investor Carl Icahn has offered to buy the company for $36 per share in cash.
600167
The investor Carl C. Icahn bid $955.9 million yesterday for WCI Communities, the Florida builder of condominiums and single-family homes, after saying he wanted to oust the board because the stock was undervalued.
422761
Lear Corp.  said on Monday that  it had accepted a higher takeover offer of about $3 billion  from billionaire Carl Icahn&#39;s American Real Estate Partners LP   after shareholders balked at the previous proposal.
205093
Mylan Laboratories Inc. (MYL.N: Quote, Profile, Research) on Monday said its board does not believe discussions with financier Carl Icahn&#39;s about his unsolicited proposal to buy the company are in the company&#39;s best interests.
404301
Mylan Laboratories Inc., the largest US maker of generic drugs, cautioned investors Friday that Thursday&#39;s jump in share price was likely driven by investor Carl Icahn&#39;s clearance to buy a large amount of company stock and fails to reflect &quot;negative ...
397700
Lear Corp. , which has faced criticism for accepting billionaire Carl Icahn's $36-per-share buyout offer, delayed a shareholder vote on the deal until July 12, the auto parts maker said on Friday.
162353
Reckson Associates Realty Corp.  has asked potential suitor, a partnership of Carl Icahn and Macklowe Associates, to pick up the pace in making a definitive bid for the New York office building owner.
226932
Billionaire financier Carl Icahn offered to buy Mylan Laboratories Inc., the largest US maker of generic medicines, for about $5.38 billion to block Mylan&#39;s proposed purchase of King Pharmaceuticals Inc.